Pages Menu
Categories Menu

Resource Links


ACTG Website

ACTG Drug Interactions Database

Centers for Disease Control (list of AIDS Defining Conditions)

DAIDS Adverse Event reporting

DAIDS Clinical Site Monitoring (CSM) Training Announcement Training Announcement

DAIDS Frequently Asked Questions Regarding DAERS


DAIDS PAB PEP Template Sample Completed DAIDS PAB PEP Template

DAIDS Regulatory and Pharmacovigilence

DAIDS Regulatory Support Center

DAIDS Required Site SOP Samples Sample Templates

FSTRF Portal


NHLBI AIDS Funding Opportunities

PPD Monitor MACE Training

We’re currently seeking study participants to take part in REPRIEVE. Please contact us to learn more.

Latest Tweets

reprievetrial @reprievetrial
REPRIEVE Trial  @reprievetrialIn a new @statnews article, Dr. Steven Grinspoon discusses how #HIV treatment has improved since the 1st… 
REPRIEVE Trial  @reprievetrialWomen w/HIV are up to 3x more likely to have a heart attack than women w/o HIV. So @reprievetrial from #NIH launche… 
REPRIEVE Trial  @reprievetrialThis #WorldAIDSDay focuses on transparency, accountability, & partnerships. @reprievetrial established the Follow Y… 
REPRIEVE Trial  @reprievetrialOn this #WorldAIDSDay, we recognize that advancements in treatment enable women with HIV to live longer. Women's re…